Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Gastrin I (human) acetate is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.
Description | Gastrin I (human) acetate is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor. |
In vitro | Gastrin I (human) acetate is the endogenous peptide produced in the stomach, and acts via cholecystokinin 2 (CCK2) receptor[1]. |
In vivo | Gastrin I (human) acetate (1.5, 5, 15 and 45 nmol/kg, i.v.) increases pepsinogen and acid secretion in rats[1]. |
Synonyms | Little gastrin I acetate, Gastrin-17 acetate, Gastrin I (human) acetate(10047-33-3 free base) |
Molecular Weight | 2158.25 |
Formula | C99H128N20O33S |
CAS No. | TP2030L1 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gastrin I (human) acetate TP2030L1 GPCR/G Protein cholecystokinin Little gastrin I acetate Gastrin-17 acetate Gastrin I (human) acetate(10047-33-3 free base) Inhibitor inhibitor inhibit